We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

38 hedge funds and large institutions have $344M invested in Cyteir Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

36% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 14

15% more funds holding

Funds holding: 33 → 38 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less capital invested

Capital invested by funds: $353M → $344M (-$8.51M)

Holders
38
Holders Change
+5
Holders Change %
+15.15%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
11
Reduced
6
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$60.3M
2
BlackRock
BlackRock
New York
+$7.32M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.07M
4
ACP
Acuta Capital Partners
California
+$2.13M
5
RCM
RA Capital Management
Massachusetts
+$1.93M

Top Sellers

Rank Fund Capital Flow
1
ABG
Ally Bridge Group
New York
-$5.74M
2
SCM
Suvretta Capital Management
New York
-$3.75M
3
MIM
Monashee Investment Management
Massachusetts
-$3.1M
4
Millennium Management
Millennium Management
New York
-$2.96M
5
HM
HealthCor Management
New York
-$2.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$79K +$84.4K +4,518 New
JP Morgan Chase
27
JP Morgan Chase
New York
$77K +$82.6K +4,418 New
SPIA
28
Steward Partners Investment Advisory
New York
$59K +$63.1K +3,375 New
Morgan Stanley
29
Morgan Stanley
New York
$56K +$58.3K +3,119 +4,456%
SO
30
STRS Ohio
Ohio
$33K +$35.5K +1,900 New
Citigroup
31
Citigroup
New York
$21K +$22.8K +1,222 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$20K +$16.5K +884 +300%
Legal & General Group
33
Legal & General Group
United Kingdom
$14K +$14.6K +782 New
AIP
34
Ameritas Investment Partners
Nebraska
$11K +$12K +641 New
UBS Group
35
UBS Group
Switzerland
$7K -$579 -31 -7%
TRCT
36
Tower Research Capital (TRC)
New York
$7K +$7.42K +397 New
Wells Fargo
37
Wells Fargo
California
$1K +$804 +43 New
SOW
38
State of Wyoming
Wyoming
$1K +$860 +46 New
SCM
39
Suvretta Capital Management
New York
– -$3.75M -175,000 Closed
MIM
40
Monashee Investment Management
Massachusetts
– -$3.1M -145,000 Closed
Millennium Management
41
Millennium Management
New York
– -$2.96M -138,165 Closed
HM
42
HealthCor Management
New York
– -$2.57M -120,000 Closed
AllianceBernstein
43
AllianceBernstein
Tennessee
– -$2.35M -110,000 Closed
Norges Bank
44
Norges Bank
Norway
– -$2.35M -110,000 Closed
MWNA
45
Marshall Wace North America
New York
– -$1.93M -90,258 Closed
Goldman Sachs
46
Goldman Sachs
New York
– -$1.33M -62,069 Closed
LP
47
LMR Partners
United Kingdom
– -$792K -36,999 Closed
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
– -$346K -16,168 Closed
ECM
49
ExodusPoint Capital Management
New York
– -$244K -11,385 Closed
MS
50
Maven Securities
Jersey
– -$217K -10,870 Closed
1
2
3

CYT Hedge Fund Activity: Q3 2021 in Review

38 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q3 2021, worth a combined $344M — down 2.4% from $353M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new CYT positions and 14 closed out — a net gain of 5 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $60.3M. The largest seller was Ally Bridge Group, cutting an estimated $5.74M.

  • 38 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q3 2021, up from 33 in Q2 2021.
  • Funds reported $344M of Cyteir Therapeutics, Inc. Common Stock stock for Q3 2021, down 2.4% quarter-over-quarter.
  • 19 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q3 2021 and 14 closed out, a net change of +5 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q3 2021 was Fidelity Investments, an estimated $60.3M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q3 2021 was Ally Bridge Group, an estimated $5.74M sold.

Based on aggregated 13F filings for Q3 2021.